<p>據 Marketbeat.com 報道，覆蓋該股票的七家經紀公司給 Cresco Labs Inc. (OTCMKTS:CRLBF - 獲取免費報告) 的股票普遍推薦為&#34;買入&#34;。兩位投資分析師給予該股票持有評級，三位給予買入評級，兩位給予強烈買入評級。過去一年內覆蓋該股票的分析師中，平均 1 年目標價為 16.00 美元。</p>
<ul>
<li>Cresco Labs 領先美國大麻市場</li>
</ul>
<p>CRLBF 最近成為多份研究報告的主題。Wedbush 將 Cresco Labs 的目標股價從 2.50 美元上調至 3.00 美元，並在 5 月 16 日星期四的研究報告中給予該股票&#34;表現優異&#34;評級。Ventum Cap Mkts 在週五的研究報告中將 Cresco Labs 評級提升至&#34;強烈買入&#34;。Needham &amp; Company LLC 在 5 月 16 日星期四的報告中重申了對 Cresco Labs 的&#34;持有&#34;評級。最後，Roth Capital 在週五的報告中將 Cresco Labs 的評級從&#34;持有&#34;上調至&#34;強烈買入&#34;。</p>
<p><strong>閲讀我們關於 CRLBF 的最新股票分析</strong></p>
<h2>Cresco Labs 股價下跌 4.0%</h2>
<ul>
<li>押注美國大麻的另外兩個理由</li>
</ul>
<p>CRLBF 週五開盤價為 1.56 美元。公司的資產負債比為 1.57，速動比率為 0.89，流動比率為 1.36。 Cresco Labs 的 52 周最低價為 1.00 美元，52 周最高價為 2.77 美元。公司的 50 天移動平均價格為 1.65 美元，200 天移動平均價格為 1.89 美元。該公司的市值為 7.615 億美元，市盈率為-3.32，β係數為 1.86。</p>
<p>Cresco Labs (OTCMKTS:CRLBF - 獲取免費報告) 上次公佈季度財報是在 8 月 8 日星期四。公司報告該季度每股收益為（0.16）美元，低於（0.01）美元的共識預期（差額為 0.15 美元）。 Cresco Labs 的淨資產收益率為-6.78%，淨利潤率為-20.32%。該季度公司的營收為 1.8436 億美元，略高於分析師預期的 1.8426 億美元。股票分析師預計，Cresco Labs 在本財年將發佈-0.03 美元的每股收益。</p>
<h2>關於 Cresco Labs（獲取免費報告）</h2>
<ul>
<li>Cresco Labs OTCMKTS: CRLBF 在第三季度加速盈利</li>
</ul>
<p>Cresco Labs Inc.及其子公司在美國種植、生產和銷售零售和醫用大麻產品。公司提供 Cresco 品牌的大麻花、霧化筆、活性樹脂、一次性筆和提取物；High Supply 品牌的霧化筆、霧化筆、花朵、爆米花、搖晃、預卷、短款和濃縮物；Good News 品牌的霧化筆和軟糖；Wonder Wellness Co 品牌的霧化筆和食用品；Remedi 品牌的滴劑、膠囊、藥膏和舌下油。</p>
<h2>精選文章</h2>
<ul>
<li>我們喜歡的五隻股票</li>
<li>投資者必須瞭解的場外（OTC）股票</li>
<li>Cassava Sciences：一個熱門股票，可以交易、投資或避免？</li>
<li>如何投資最佳的加拿大股票</li>
<li>MarketBeat 周評 - 8/5 - 8/9</li>
<li>投資石油股的方法和原因</li>
<li>大麻行業：盈利能力成為焦點</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG"/></p>
<p><em>此即時新聞警報由 MarketBeat 的敍事科技和金融數據生成，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<p>→ 美國正在研發 “結束戰爭的超級武器”？（來自 Paradigm Press）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTMw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTMw"/></p>
<h2>您現在是否應該投資 1000 美元購買 Cresco Labs 股票？</h2>
<p>在考慮 Cresco Labs 之前，您可能想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂尖和表現最佳的研究分析師以及他們建議客户購買的股票。MarketBeat 已確定了五隻頂尖分析師悄悄告訴客户在更廣泛市場注意之前現在購買的股票... Cresco Labs 不在名單上。</p>
<p>儘管 Cresco Labs 目前在分析師中有&#34;中等買入&#34;評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

CRLBF

<p>Cresco Labs Inc.收到分析師一致的 “買入” 推薦。該股票有兩個持有評級，三個買入評級和兩個強烈買入評級。平均目標價格為 16.00 美元。Cresco Labs 是美國大麻市場的領先公司。該公司報告了本季度的每股收益為負值和負淨利潤率。該公司的股價開盤價為 1.56 美元</p>

<p>Shares of Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) have received a consensus recommendation of &#34;Buy&#34; from the seven brokerages that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and two have assigned a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $16.00.</p>
<ul>
<li>Cresco Labs Is Leading The U.S. Cannabis Market</li>
</ul>
<div class="lb-trans"><p>據 Marketbeat.com 報道，覆蓋該股票的七家經紀公司給 Cresco Labs Inc. (OTCMKTS:CRLBF - 獲取免費報告) 的股票普遍推薦為&#34;買入&#34;。兩位投資分析師給予該股票持有評級，三位給予買入評級，兩位給予強烈買入評級。過去一年內覆蓋該股票的分析師中，平均 1 年目標價為 16.00 美元。</p>
<ul>
<li>Cresco Labs 領先美國大麻市場</li>
</ul>
</div><p>CRLBF has been the topic of several recent research reports. Wedbush increased their price objective on shares of Cresco Labs from $2.50 to $3.00 and gave the stock an &#34;outperform&#34; rating in a research note on Thursday, May 16th. Ventum Cap Mkts raised Cresco Labs to a &#34;strong-buy&#34; rating in a research note on Friday. Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of Cresco Labs in a report on Thursday, May 16th. Finally, Roth Capital upgraded Cresco Labs from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday.</p>
<div class="lb-trans"><p>CRLBF 最近成為多份研究報告的主題。Wedbush 將 Cresco Labs 的目標股價從 2.50 美元上調至 3.00 美元，並在 5 月 16 日星期四的研究報告中給予該股票&#34;表現優異&#34;評級。Ventum Cap Mkts 在週五的研究報告中將 Cresco Labs 評級提升至&#34;強烈買入&#34;。Needham &amp; Company LLC 在 5 月 16 日星期四的報告中重申了對 Cresco Labs 的&#34;持有&#34;評級。最後，Roth Capital 在週五的報告中將 Cresco Labs 的評級從&#34;持有&#34;上調至&#34;強烈買入&#34;。</p>
</div><p><strong>Read Our Latest Stock Analysis on CRLBF</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 CRLBF 的最新股票分析</strong></p>
</div><h2>Cresco Labs Trading Down 4.0 %</h2>
<ul>
<li>Two More Reasons To Bet Big On U.S. Cannabis</li>
</ul>
<div class="lb-trans"><h2>Cresco Labs 股價下跌 4.0%</h2>
<ul>
<li>押注美國大麻的另外兩個理由</li>
</ul>
</div><p>Shares of CRLBF opened at $1.56 on Friday. The company has a debt-to-equity ratio of 1.57, a quick ratio of 0.89 and a current ratio of 1.36. Cresco Labs has a 52-week low of $1.00 and a 52-week high of $2.77. The business's fifty day moving average is $1.65 and its 200-day moving average is $1.89. The firm has a market cap of $761.50 million, a price-to-earnings ratio of -3.32 and a beta of 1.86.</p>
<div class="lb-trans"><p>CRLBF 週五開盤價為 1.56 美元。公司的資產負債比為 1.57，速動比率為 0.89，流動比率為 1.36。 Cresco Labs 的 52 周最低價為 1.00 美元，52 周最高價為 2.77 美元。公司的 50 天移動平均價格為 1.65 美元，200 天移動平均價格為 1.89 美元。該公司的市值為 7.615 億美元，市盈率為-3.32，β係數為 1.86。</p>
</div><p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.15). Cresco Labs had a negative return on equity of 6.78% and a negative net margin of 20.32%. The company had revenue of $184.36 million for the quarter, compared to analysts' expectations of $184.26 million. Equities analysts anticipate that Cresco Labs will post -0.03 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Cresco Labs (OTCMKTS:CRLBF - 獲取免費報告) 上次公佈季度財報是在 8 月 8 日星期四。公司報告該季度每股收益為（0.16）美元，低於（0.01）美元的共識預期（差額為 0.15 美元）。 Cresco Labs 的淨資產收益率為-6.78%，淨利潤率為-20.32%。該季度公司的營收為 1.8436 億美元，略高於分析師預期的 1.8426 億美元。股票分析師預計，Cresco Labs 在本財年將發佈-0.03 美元的每股收益。</p>
</div><h2>About Cresco Labs (Get Free Report</h2>
<ul>
<li>Cresco Labs OTCMKTS: CRLBF Accelerates To Profits In Q3</li>
</ul>
<div class="lb-trans"><h2>關於 Cresco Labs（獲取免費報告）</h2>
<ul>
<li>Cresco Labs OTCMKTS: CRLBF 在第三季度加速盈利</li>
</ul>
</div><p>Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.</p>
<div class="lb-trans"><p>Cresco Labs Inc.及其子公司在美國種植、生產和銷售零售和醫用大麻產品。公司提供 Cresco 品牌的大麻花、霧化筆、活性樹脂、一次性筆和提取物；High Supply 品牌的霧化筆、霧化筆、花朵、爆米花、搖晃、預卷、短款和濃縮物；Good News 品牌的霧化筆和軟糖；Wonder Wellness Co 品牌的霧化筆和食用品；Remedi 品牌的滴劑、膠囊、藥膏和舌下油。</p>
</div><h2>Featured Articles</h2>
<ul>
<li>Five stocks we like better than Cresco Labs</li>
<li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li>
<li>Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?</li>
<li>How to Invest in the Best Canadian Stocks</li>
<li>MarketBeat Week in Review – 8/5 - 8/9</li>
<li>The How And Why of Investing in Oil Stocks</li>
<li>The Cannabis Sector: Profitability Takes Center Stage</li>
</ul>
<div class="lb-trans"><h2>精選文章</h2>
<ul>
<li>我們喜歡的五隻股票</li>
<li>投資者必須瞭解的場外（OTC）股票</li>
<li>Cassava Sciences：一個熱門股票，可以交易、投資或避免？</li>
<li>如何投資最佳的加拿大股票</li>
<li>MarketBeat 周評 - 8/5 - 8/9</li>
<li>投資石油股的方法和原因</li>
<li>大麻行業：盈利能力成為焦點</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=OTCMKTS&amp;Symbol=CRLBF"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由 MarketBeat 的敍事科技和金融數據生成，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><p>→ US developing “war ending superweapon”? (From Paradigm Press)(Ad)</p>
<div class="lb-trans"><p>→ 美國正在研發 “結束戰爭的超級武器”？（來自 Paradigm Press）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTMw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9130&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Cresco Labs right now?</h2>
<div class="lb-trans"><h2>您現在是否應該投資 1000 美元購買 Cresco Labs 股票？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cresco Labs 之前，您可能想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂尖和表現最佳的研究分析師以及他們建議客户購買的股票。MarketBeat 已確定了五隻頂尖分析師悄悄告訴客户在更廣泛市場注意之前現在購買的股票... Cresco Labs 不在名單上。</p>
</div><p>While Cresco Labs currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Cresco Labs 目前在分析師中有&#34;中等買入&#34;評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Cresco Labs Inc. (OTCMKTS:CRLBF) 獲得分析師一致推薦的 “買入” 評級